Tag Archives | ASCO

2017 Life Science Review #1: Big Biotech Gains for First Half

Big Biotech Gains for Stocks in First Half Rayno Life Science Picks Top Winners YTD: Foundation Medicine (FMI) up 124.6%, bluebird bio (BLUE) up 70.26%, XBI up 20.9%. Large cap winners since inception: Abbvie (ABBV) and Roche ADR (RHHBY). 6/27 Take some profits on XBI at $78. XBI is our top ETF pick. XLV SPDR […]

Continue Reading 0

BIOtech Breakout: Healthcare Stocks Lead the Way…Update-1

6/27/17 Red Screen Day: Sell-Off in Biotechs Possibly Due to Senate Delay in Healthcare Vote IBB down 1.54% at $314.80. Momentum stocks are weak; NASDAQ down 1.2%. Take profits on XBI trade at $78 range after 34% move YTD. Allow time for arm twisting by Republicans after JY 4. ======== Biotech Breakout Continues with Larger […]

Continue Reading 0

Biotech Avoids Tech Wreck of June 9…Update-2 June 15

June 15-Update 2 after close…Biotechs Down with Techs-Red Screen Day Very few winners today: IBB down 0.77%, XBI down 1.36% to $71.55 near 52 week high of $73. ABBV near new highs at $70.60, BLUE up 24.7% for past month. EPZM soars 17% on EZH2 inhibitor, RXDX up 5.8% continues run on NTRK inhibitor. Trump Executive […]

Continue Reading 0

ASCO Update #2: Stock Performance Data as of 6/8/17

ASCO Update: Many Stocks Rallied on the News Over the Past Month ASCO Rally is Holding but Fails to Break Through to New 2017 Highs The stock performance of most companies with ASCO news is summarized below.Biotechnology stocks are driven by clinical and deal news so here are some trends to consider: Anticipation of positive […]

Continue Reading 0

ASCO Update: Movers on the News-INCY PBYI RHHBY

June 5…ASCO Update: Incyte Puma and Roche A lot of the product news is already “baked into” stock prices but here is a brief summary of big movers today on clinical news updates. The bellwether XBI peaked at $71.72 today and is down 0.62% to $70.66. bluebird bio (BLUE) up 8.5% to $91.30 BLUE soared […]

Continue Reading 0

Biotechs Sink Again in Sector Shift to Technology Stocks: Update-1

6/1/17 Update at close…Biotechs Bounce off Bottom of 3 Month Trading Range IBB up 1.8% back above $290 after hitting 200 SMA bottom. XBI up 2.7% to $69.54 at SMA 50. XBI 2017 top is $72. XLV a safer play up over 1% to $76.91; above March highs and near 12 mo. highs up 11.58% […]

Continue Reading 0

Biotech Fades After ASCO Abstract Rally

Biotech Fades with Profit Taking: Is the pre-ASCO Momentum Gone?  Technicals Matter  Drug Pricing Scrutiny Continues Biotechs faded today now that the rush of oncology drug news slowed down. NASDAQ retained momentum with the ETF leader QQQ up 19% YTD pulling ahead of the biotech ETFs. Large cap tech stocks rule. The large cap centric […]

Continue Reading 0

ASCO Abstracts Week: Biotech Trends and Hot Stocks

Biotech Trends: Immuno-Oncology Stocks Trending Strong Await ASCO Meeting on June 2 Prices as of Monday 11:45A with NASDAQ up 0.73% FBT $106.75 up 0.2%, IBB flat at $290.64, XBI at $69.33 up 0.3% Here is a selection of  biotech trending stocks that have had significant moves or released ASCO Abstract news last week. The […]

Continue Reading 0

Biotechs Mired in a Trading Range: Breakout Delayed…Update-3

Update-3…ASCO Movers Today 5/18:  IBB up 1.28% to $292.27, XBI up 2% to $70. Nice follow through in biotech after a nasty day on 5/17 attributed to ASCO and a move away from the “Trump Trade” (industrials and materials).  Mid-caps and small caps were very strong. Large Caps: MRK up 1.35%,REGN up 2.38%. Mid Caps: […]

Continue Reading 0

Biotech Blahs: Unable To Hold Gains After ASCO Run-Up…Update-1

Monday June 20… Update 4:30p EDT…BRexit relief rally Biotech stocks pretty much tracked the NASDAQ rally today slowly selling off as the day wore on. The more volatile XBI was still up 1.56% for the day beating the sluggish IBB up 0.91%. The healthcare sector overall held up about 1%. Energy and materials led up […]

Continue Reading 0